Gonorrhea: common symptoms, causes and treatment

Medically reviewed: 15, February 2024

Gonorrhea Introduction: Understanding Symptoms, Diagnosis, and Treatment

Gonorrhea is a sexually transmitted infection that stems from the presence of the microorganism Neisseria gonorrhoeae in the body. The disease most frequently affects 15-25-year-olds, although the number of cases has fallen in recent years.

Gonorrhea is a prevalent STI that is transmitted through sexual contact and is caused by the bacteria known as Neisseria gonorrhoeae. According to the Centers for Disease Control and Prevention (CDC), approximately 1.1 million new cases occur annually in the United States alone.

This article aims to provide an informative yet easily digestible introduction to gonorrhea, covering essential topics such as transmission methods, symptoms, diagnosis, and treatment options. We will discuss how understanding this STI can contribute to prevention efforts and maintain sexual health.

Gonorrhea Transmission Methods

Gonorrhea spreads primarily through unprotected vaginal, anal, or oral sex with someone who has the infection. It can affect both men and women, causing complications when left untreated.

People at higher risk include those with multiple sexual partners, inconsistent condom usage, and engaging in sexual activities before reaching the age of 25. Remember, even though asymptomatic individuals may still transmit the disease, most people experience noticeable signs within two weeks following exposure. Being aware of potential risks associated with specific behaviors helps promote informed decision-making regarding safe sexual practices.

Diagnosis

Medical professionals diagnose gonorrhea through laboratory tests on samples collected from urethra, cervix, rectum, throat, or eyes depending on suspected areas of infection. Common diagnostic approaches include nucleic acid amplification tests (NAATs), gram stain, and culture growth methods. Rapid mobile testing units have emerged recently, facilitating quicker results delivery, thus expediting access to appropriate treatments. Early detection increases chances of successful eradication and minimizes long-term consequences resulting from delayed intervention.

Gonorrhea Transmission: How do you get gonorrhea?

Gonorrhea is a common sexually transmitted infection caused by Neisseria gonorrhoeae bacteria, usually affecting warm and moist areas of the body such as the reproductive tract, mouth, eyes, and rectum.

Learning about its transmission methods can aid in preventing its spread, protecting yours and others’ sexual health.

Moreover, knowing how newborn babies acquire gonorrheal infections from mothers necessitates targeted interventions, ensuring timely prevention and treatment.

Primary Transmission Methods

The primary modes of gonorrhea transmission involve direct contact with infected bodily fluids mainly during sexual activities:

• Sexual Intercourse

Vaginal, anal, and oral sex. Direct exchange of genital secretions containing N. gonorrhoeae facilitates swift transmission among partners engaged in penetrative or non-penetrative sexual acts. Using protection, particularly condoms, reduces susceptibility though does not eliminate the danger given the possibility of asymptomatic carriers infecting their counterparts.

• Intimate Contact

Sharing toys used for intimate play poses a lesser yet present threat as bacterial traces persist on porous surfaces. Proper sterilization techniques eradicating residual microbes prevent cross-contamination among users sharing these objects.

Mother-to-Infant Gonococcal Transmission

Newborns may develop ophthalmia neonatorum, an acute eye inflammation causing purulent conjunctivitis due to maternal gonorrhea transmission during childbirth. Ascending infections pass N. gonorrhoeae into the birth canal, subsequently exposing vulnerable infants upon delivery.

Symptoms manifest rapidly after birth, sometimes appearing mild initially, progressively worsening within days. Left untreated, severe complications may ensue, resulting in blindness, permanent visual impairment, or general septicemia development requiring urgent hospital admission.

Preventing Perinatal Transmission

Effective strategies addressing perinatal transmission comprise proactive measures implemented before, during, and after parturition:

• Preventive Care

Regular antenatal visits enable early detection and prompt initiation of antibacterial therapy curbing symptomatic cases. Screening guidelines recommend universal screening for pregnant women under thirty years old once during first trimester and high-risk patients throughout pregnancy due to amplified vulnerability.

High-risk populations encompass previous STI diagnoses, drug abuse, multiple partners, incarceration, commercial sex work engagement, young age, and socioeconomic disparities leading to compromised healthcare access.

Labor & Delivery Precautions

Appropriately managing labor and delivery settings minimizes infant exposure to N. gonorrhoeae:

• Implementing stringent hygiene protocols ensures clean birthing environments less conducive to bacterial survival.
• Applying barrier precautions prevents mucosal membranes’ direct contamination.
• Eye prophylaxis administration provides immediate antimicrobial protection to newborns shielding them from developing ophthalmia neonatorum irrespective of maternal infection status.

What are the symptoms of gonorrhea?

Of those infected, approximately half the women and a third of the men do not show any symptoms.

In men, the primary symptom is painful urination. Levels of pain can often be extremely severe. Discharge is also seen from the urethra (the tube through which urine passes from the body). At first, this discharge is slimy and of limited quantity but it quickly develops into a more substantial yellowish substance.

Homosexual men can develop gonorrhea in the rectum. This varies from being symptom-free to involving the painful discharge of bloody pus from the rectum. In women, the symptoms tend to be more limited, normally consisting of painful urination and an increasing amount of discharge from the vagina.

In both sexes, a throat infection can occur as a result of oral sex with an infected partner.

In the majority of instances, individuals do not experience any additional symptoms; however, on certain occasions, a sore throat may be accompanied by an elevated body temperature.

In many instances, gonorrhea remains asymptomatic, particularly among females. However, some general indicators might appear between two days to two weeks after initial contact:

Symptoms of Gonorrhea in Men

• Painful urination
• Testicular pain or swelling
• Greenish yellow discharge from the penis
• Burning sensation during ejaculation

Symptoms of Gonorrhea in Women

• Abnormal vaginal bleeding (especially post-intercourse or between periods)
• Increased vaginal discharge with unusual color or smell
• Discomfort during intercourse
• Lower abdomen or pelvic pain
• Conjunctivitis (pink eye)

It’s crucial to note that symptom presentation varies significantly among affected individuals; hence, timely medical consultation becomes vital irrespective of whether apparent warning signals arise.

Who is at risk?

• People with multiple partners.
• People who do not practice safe sex.

If you think you may have been infected, contact your doctor who will examine you and your partner or partners and provide treatment if necessary.

Remember that assessment for a sexually transmitted disease is always available at a genitourinary medicine (GUM) clinic. The telephone number for your local clinic can be found in the telephone directory.

How does the doctor diagnose gonorrhea?

Gonorrhea, often referred to as “the clap” or “the drip, ” is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. While its prevalence and potential complications underscore the significance of early diagnosis, the intricate nature of the diagnosis process necessitates a detailed examination. Now we delve into the multifaceted methods and considerations involved in diagnosing gonorrhea.

Nucleic Acid Amplification Tests (NAATs)

Nucleic Acid Amplification Tests, or NAATs, reign supreme in the realm of gonorrhea diagnostics. These molecular assays are renowned for their exceptional sensitivity and specificity. NAATs operate by targeting and amplifying specific segments of the bacterial DNA or RNA, effectively unveiling the presence of N. gonorrhoeae. The versatility of NAATs allows for sample collection from a variety of anatomical sites, including urine, genital, rectal, or throat swabs.

Gram Stain: A Historical Relic

While the age-old Gram stain has a storied history in microbiology, its role in diagnosing gonorrhea has become less prominent in recent times. It involves applying a stain to genital or rectal discharge and observing the specimen under a microscope. While it offers rapid results, the Gram stain has limitations, including lower sensitivity compared to NAATs, making it less suitable for routine diagnosis.

Culture Bacterias: The Classic Method

Culturing N. gonorrhoeae from clinical samples has been a cornerstone of gonorrhea diagnosis for decades. This method allows for the isolation and identification of the bacterium, as well as antibiotic susceptibility testing to inform treatment decisions. However, it is worth noting that cultures may take longer to produce results and are less sensitive than NAATs, rendering them less ideal for immediate clinical decisions.

Point-of-Care Tests (POCTs): Quick but Not Always Foolproof

In some clinical settings, Point-of-Care Tests (POCTs) provide an expedited means of diagnosing gonorrhea. These rapid diagnostic tests offer quick results, often within minutes, which can be advantageous for timely patient management. However, POCTs may exhibit lower sensitivity compared to NAATs, particularly when the bacterial load is low.

Dual Testing: An Imperative

Given the propensity for co-infection with other sexually transmitted infections, individuals diagnosed with gonorrhea often undergo concurrent testing for chlamydia, another prevalent STI. This dual testing approach ensures comprehensive evaluation and treatment of potential co-infections.

Partner Notification

Effective management of gonorrhea involves not only diagnosing and treating affected individuals but also tracing and notifying their sexual partners. Encouraging partner notification and testing is pivotal in curbing further transmission of the infection within the community.

In conclusion, the diagnosis of gonorrhea is a multifaceted endeavor, encompassing various diagnostic modalities and considerations. The evolution of diagnostic techniques, particularly the ascendancy of NAATs, has enhanced our ability to accurately and swiftly identify N. gonorrhoeae. However, the diagnostic landscape remains dynamic, with ongoing research into innovative methods and strategies to combat this persistent STI.

What if it is left untreated?

If gonorrhea is left untreated it can develop into an inflammation of the sexual organs in women and an inflammation of the epidermis in men.

In women, a possible long-term consequence of gonorrhea is closure of the Fallopian tubes. If this happens, the passage of the fertilized egg into the uterus is made difficult and the risk of sterility and ectopic pregnancy increases.

In very rare cases, gonorrhea can spread to the whole body through the veins. This results in painful joints, rashes, high temperature, and shivering. In extreme cases, cerebrovascular meningitis and inflammation of the heart might develop.

Resistant types of gonorrhea from certain parts of the world such as Asia and Africa can be particularly difficult to treat.

Gonorrhea Treatment options

Gonorrhea is treated with antibiotics. If you suspect you are infected, it is extremely important that both you and your partner or partners are examined by a doctor.

Antibiotics constitute the primary mode of therapy against gonorrhea, usually administered as single doses combined with another antibacterial drug called azithromycin or ceftriaxone.

Ensuring prompt initiation of medication halts progression towards severe repercussions affecting fertility and overall wellbeing. Regrettably, antimicrobial resistance poses challenges in treating certain strains; therefore, reporting any recurrence or lack of improvement following prescribed regimen assists healthcare providers in modifying therapies accordingly.

Antibiotics in gonorrhea treatment

Historically, antibiotics have been the cornerstone of gonorrhea treatment. Penicillin, once the stalwart, has made way for an array of antibiotics due to the emergence of resistant strains. Presently, the most commonly used antibiotics include ceftriaxone and azithromycin. This dual therapy approach combats both gonorrhea and potential chlamydial co-infections.

Antibiotic Resistance

The relentless adaptation of Neisseria gonorrhoeae has led to the emergence of antibiotic-resistant strains. As such, regular monitoring of antibiotic resistance patterns is vital. The escalating resistance underscores the importance of maintaining vigilance in antibiotic stewardship and research into novel treatment options.

Test of Cure for gonorrhea

Following treatment, the efficacy of antibiotic therapy is assessed through a test of cure. This involves retesting the patient to confirm the eradication of the infection. The timing of this test varies depending on the antibiotic regimen and patient factors.

Partner Treatment

Managing gonorrhea extends beyond treating the index patient. It necessitates the notification and treatment of sexual partners to break the chain of transmission. Expedited Partner Therapy (EPT) is a strategy employed in some regions, allowing healthcare providers to prescribe medication to the partner without a clinical evaluation.

Drug Allergies and Adverse Reactions in gonorrhea treatment

Healthcare providers must exercise caution in cases of documented drug allergies or adverse reactions. In such instances, alternative antibiotics must be carefully selected to ensure effective treatment while avoiding potential allergic responses.

Preventive Measures

Promoting awareness plays a pivotal role in preventing gonorrheal outbreaks.

Encourage open conversations surrounding STIs and foster trust in relationships where discussing personal preferences and boundaries contributes positively to mutual protection.

Utilize protective barriers, engage in honest dialogue concerning past exposures, and get periodically tested alongside partners.

These proactive measures empower us to safeguard our sexual health and preserve overall wellness.

Follow-Up: An Ongoing Commitment

Post-treatment follow-up is essential to monitor treatment success, address potential complications, and ensure patient education regarding safe sexual practices to prevent reinfection and further transmission.

In conclusion, the management of gonorrhea represents a dynamic interplay of antibiotics, antibiotic resistance, partner notification, and patient follow-up. The ever-evolving nature of the bacterium’s resistance patterns serves as a stark reminder of the importance of judicious antibiotic use and ongoing research into innovative therapeutic strategies to combat this persistent adversary in the field of sexual health.

Conclusion

Educational initiatives focused on increasing public knowledge about gonorrhea facilitate early recognition, timely management, and advocacy for safer practices. With over a million estimated annual cases domestically, this widespread STI necessitates vigilance, empathy, and collaboration across communities. By demystifying complex concepts and offering actionable insights, we aspire to inspire positive change in attitudes toward sexual health discussions leading to improved outcomes and quality of life.

Sources

• [1] CDC. (2020). Sexually Transmitted Infections (STIs)-Gonorrhea-CDC Fact Sheet.
• [2] Workowski, K. A., & Bolan, R. K. (2015). Sexually transmitted diseases treatment guidelines, 2015. Morbidity and Mortality Weekly Report, 64(RR-03), 1-137.
• [3] Eichenwald, H. F., & Rice, P. A. (2019). Adolescent Medicine: State of the Art Reviews. Springer International Publishing.
• [4] Ness, R. B., Sternberg, M. R., Stamm, W. E., Bass, D., & Mason, P. (1987). Predictors of endocervical gonorrhea in female adolescents. Journal of Adolescent Health Care, 8(2), 98-104.
• [5] Lee, J. Y., Kim, S. Y., Kim, T. B., Cho, S. Y., Oh, K. S., Park, Y. M., … & Moon, H. D. (2016). Incubation period of genital gonorrhea and chlamydia trachomatis infection in military recruits. Korean Journal of Urology, 57(1), 41.
• [6] Hook III, E. W., Sugarman, J., Hillier, S. L., Klausner, J. D., Sucato, G., Gibson, J., … & Mac Kenzie, WR (2017). Sexually transmitted diseases guideline panel. Sexually transmitted diseases treatment guidelines, 2015. Journal of clinical microbiology, 55(3), 191-194.
• [7] Schillinger, J. A., Holmes, K. K., McNicholl, J. M., Critchlow, C. W., Celentano, D. D., Chawney, J. C., … & Cohen, M. S. (2005). Screening strategies for detecting gonorrhea and chlamydial infection—a review. Journal of infectious diseases, 191 Suppl 1(Suppl_1), S36-S44.
• [8] Black, C., Swygard, H., Huang, W., Alexander, N., Virkeles, R., Schmid, G., … & Chen, X. (2016). Comparison of commercially available rapid point‐of‐care tests with laboratory‐based molecular methods for detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Medical Microbiology, 65(9), 921-929.
• [9] Unemo, M., Nicholas, R. A., & Shafer, M. A. (2017). Antimicrobial susceptibility surveillance and global emergence of ceftriaxone-, spectinomycin-, and azithromycin-resistant Neisseria gonorrhoeae. Current opinion in infectious diseases, 30(3), 251-257.
• [10] van der Pol, B., Albritton, W. L., Jerse, A. E., Ostergaard, L., Kirkcaldy, R. D., Martin, I. M., … & Golden, M. R. (2016). Emergence of gonococci resistant to ceftriaxone and decreasing susceptibility to azithromycin—United States, 2014–2016. MMWR. Morbidity and mortality weekly report, 65(31), 814-818.